Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2023	Jul. 31, 2022
Current assets
Cash	$ 7	$ 15
Prepaid expenses	16	6
Total current assets	23	21
Total assets	23	21
Current liabilities
Accounts payable and accrued expenses	240	219
Current liabilities - discontinued operations	51	51
Total current liabilities	291	270
Total liabilities	635	434
Shareholders’ deficit
Series B Preferred Stock, par value $1.00 per share; 100 shares authorized, issued and outstanding; liquidation preference $10
Common Stock, par value $0.01 per share; 400,000,000 shares authorized; 154,810,655 shares issued and outstanding as of July 31, 2023 and 2022, respectively	1,548	1,548
Additional paid in capital	26,574	26,574
Accumulated deficit	(28,734)	(28,535)
Total shareholders’ deficit	(612)	(413)
Total liabilities and shareholders’ deficit	23	21
Related Party [Member]
Current liabilities
Notes payable – related parties	300	150
Accrued interest – related parties	$ 44	$ 14